Elisa Escabia

Prof. Elisa Escabia

Uppsala University, IMBIM
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2023 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
JGJuan Carlos Gabaldon
Juan Carlos Gabaldon
MSMalia Skjefte
Malia Skjefte
SLSilvia Longhi
Silvia Longhi
Elisa EscabiaElisa Escabia
Elisa Escabia
LGLady Juliette García
Lady Juliette García
JPJulio Alonso Padilla
Julio Alonso Padilla
Chagas disease, caused by parasite Trypanosoma cruzi, is the most important neglected tropical disease in the Americas. Two drugs are available for treatment, but access to them is challenging, in part due to complex diagnostic algorithms. These are stage-dependent, involve multiple tests and are ill-adapted to the reality of vast areas where the disease is endemic. Molecular and serologic tools are used to detect acute and chronic infections, with the performance of the latter showing geographic differences. Breakthroughs in the development of new diagnostic tools include the validation of a loop-mediated isothermal amplification assay for acute infections (T. cruzi-LAMP), and the regional validation of several rapid diagnostic tests (RDTs) for chronic infection, which simplify testing in resource-limited settings. The literature search was carried out in the MEDLINE database until NaN Invalid Date NaN. This review outlines existing algorithms, and proposes new ones focused on point-of-care testing. Integrating point-of-care testing into existing diagnostic algorithms in certain endemic areas will increase the access to timely diagnosis and treatment. However, additional research is needed to validate the use of these techniques across a wider geography, and to better understand the cost-effectiveness of their large-scale implementation.

23 September 2021 in Environments
Verified
Journal Article
Open access
PDF file
Farhan R. KhanFarhan R. Khan
Farhan R. Khan
SCStephanie Storebjerg Croft
Stephanie Storebjerg Croft
Elisa EscabiaElisa Escabia
Elisa Escabia
AKAthanasios Kandylas
Athanasios Kandylas
TMTabea Meyerjuergens
Tabea Meyerjuergens
ILIngmar Valdemarson á Løgmansbø
Ingmar Valdemarson á Løgmansbø
A convincing case has been made that the scale of human activity has reached such pervasiveness that humans are akin to a force of nature. How environmental science responds to the many new challenges of the Anthropocene is at the forefront of the field. The aim of this perspective is to describe Anthropocene as a concept and a time period and discuss its relevance to the contemporary study of environmental science. Specifically, we consider areas in environmental science which may need to be revisited to adjust to complexity of the new era: (a) recalibrate the idea of environmental baselines as Anthropogenic baselines; (b) rethink multiple stressor approaches to recognize a system under flux; (c) re-evaluate the relationship of environmental science with other disciplines, particularly Earth Systems Science, but also social sciences and humanities. The all-encompassing nature of the Anthropocene necessitates the need to revise and reorganize to meet the challenge of complexity.

28 August 2024 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
ARAlbert Ros-Lucas
Albert Ros-Lucas
JGJuan Carlos Gabaldon
Juan Carlos Gabaldon
Nieves MartínezNieves Martínez
Nieves Martínez
IGIrene Losada Galván
Irene Losada Galván
EPElizabeth Posada
Elizabeth Posada
JPJulio Alonso Padilla
Julio Alonso Padilla
Chagas disease is a neglected tropical infection that affects millions of people. This study explores transcriptomic changes in T. cruzi-infected subjects before and after treatment. Using total RNA sequencing, gene transcription was analyzed in peripheral blood mononuclear cells from asymptomatic (n=19) and symptomatic (n=8) T. cruzi-infected individuals, and non-infected controls (n=15). Differential expression was compared across groups, and before/after treatment in infected subgroups. Untreated infection showed 12 upregulated and 206 downregulated genes in all T. cruzi-infected subjects, and 47 upregulated and 215 downregulated genes in the symptomatic group. Few differentially expressed genes were found after treatment and between the different infected groups. Gene set enrichment analysis highlighted immune-related pathways activated during infection, with therapy normalizing immune function. Changes in the kynurenine/tryptophan ratio, increased pre-treatment, suggested chronic immune fatigue, which was restored post-treatment. These differentially expressed genes offer insights for potential biomarkers and pathways associated with disease progression and treatment response.